MANNKIND CORP Business Finance Contracts & Agreements

68 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Common Stock
Stock Agreements
MANNKIND CORP
Biotechnology
2024
MannKind Corporation 2004 Employee Stock Purchase Plan Adopted by the Board of Directors March 23, 2004 Approved by Stockholders March 23, 2004 Amended by the Board of Directors...
Stock Agreements
MANNKIND CORP
Biotechnology
2023
Amendment No. 9 to Credit and Security Agreement, dated November 8, 2021, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust
Credit Agreements
MANNKIND CORP
Biotechnology
CA
2023
Amendment No. 8 to Credit and Security Agreement, dated November 3, 2021, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust
Credit Agreements
MANNKIND CORP
Biotechnology
CA
2023
Amendment No. 10 to the Credit and Security Agreement, dated August 29, 2022, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust
Credit Agreements
MANNKIND CORP
Biotechnology
CA
2022
Purchase and Sale Agreement, dated September 23, 2021, by and between MannKind Corporation and 1 Casper, LLC
Purchase Agreements
MANNKIND CORP
Biotechnology
FL
2021
Indenture, dated as of March 4, 2021, by and between MannKind Corporation and U.S. Bank National Association, as Trustee
Indenture Agreements
MANNKIND CORP
Biotechnology
DE
2021
Description of Common Stock
Stock Agreements
MANNKIND CORP
Biotechnology
2021
Amendment No. 4 to Credit and Security Agreement, dated December 7, 2020 by and among the Company, MannKind LLC and MidCap Financial Trust
Credit Agreements
MANNKIND CORP
Biotechnology
CA
2020
Purchase Agreement, dated December 7, 2020 by and among the Company, the Acquired Company, the Sellers and the Securityholders Representative
Purchase Agreements
MANNKIND CORP
Biotechnology
DE
2020
Description of Common Stock
Stock Agreements
MANNKIND CORP
Biotechnology
2020
Amendment to Common Stock Purchase Warrant, dated December 22, 2019, by and between MannKind Corporation and CVI Investments, Inc
Warrant Agreements
MANNKIND CORP
Biotechnology
2019
Form of 5.75% Convertible Senior Subordinated Exchange Notes Due 2024 (included in Exhibit 4.3 as Exhibit A thereto)
Note Agreements
MANNKIND CORP
Biotechnology
DE
2019
Promissory Note made by MannKind Corporation in favor of The Mann Group LLC, dated August 6, 2019
Note Agreements
MANNKIND CORP
Biotechnology
NY
2019
Convertible Promissory Note made by MannKind Corporation in favor of The Mann Group LLC, dated August 6, 2019
Note Agreements
MANNKIND CORP
Biotechnology
NY
2019
Promissory Note due December 31, 2020 made by MannKind Corporation in favor of Bruce & Co., Inc., dated August 6, 2019
Note Agreements
MANNKIND CORP
Biotechnology
NY
2019
Promissory Note due June 30, 2020 made by MannKind Corporation in favor of Bruce & Co., Inc., dated August 6, 2019
Note Agreements
MANNKIND CORP
Biotechnology
NY
2019
Form of Warrant to Purchase Stock
Warrant Agreements
MANNKIND CORP
Biotechnology
DE
2019
Form of Common Stock Purchase Warrant
Warrant Agreements
MANNKIND CORP
Biotechnology
NY
2018
Underwriting Agreement, dated December 19, 2018, by and between MannKind Corporation and Leerink Partners LLC, as representative of the several underwriters named therein
Underwriting Agreements
MANNKIND CORP
Biotechnology
NY
2018
Form of Common Stock Purchase Warrant
Warrant Agreements
MANNKIND CORP
Biotechnology
2018
Indenture, by and between the Company and U.S. Bank National Association, dated October 30, 2017
Indenture Agreements
MANNKIND CORP
Biotechnology
DE
2017
FIRST AMENDMENT TO AGREEMENT OF PURCHASE AND SALE AND JOINT ESCROW INSTRUCTIONS
Escrow Agreements
MANNKIND CORP
Biotechnology
2017
SERIES B COMMON STOCK PURCHASE WARRANT MANNKIND CORPORATION
Warrant Agreements
MANNKIND CORP
Biotechnology
2016
FORM OF SERIES ACOMMON STOCK PURCHASE WARRANT MANNKIND CORPORATION
Warrant Agreements
MANNKIND CORP
Biotechnology
2016
EXHIBIT A SEPARATION DATE RELEASE (Tobe signed on or within 45 days after the Separation Date.)
Release Agreements
MANNKIND CORP
Biotechnology
CA
2016
EXHIBIT A SEPARATION DATE RELEASE (To be signed on or within 21 days after the Separation Date.)
Release Agreements
MANNKIND CORP
Biotechnology
CA
2016
MANNKIND CORPORATION WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
MANNKIND CORP
Biotechnology
DE
2016
A-1 MANNKIND CORPORATION 5.75% Convertible Senior Subordinated Exchange Notes due 2015
Note Agreements
MANNKIND CORP
Biotechnology
2015
MANNKIND CORPORATION AND U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of August 14, 2015 5.75% Convertible Senior Subordinated Exchange Notes due 2015 TABLE OF...
Indenture Agreements
MANNKIND CORP
Biotechnology
DE
2015
MANNKIND CORPORATION 5.75%Convertible Senior Subordinated Exchange Notes due 2018
Note Agreements
MANNKIND CORP
Biotechnology
2015
MANNKIND CORPORATION AND WELLS FARGO BANK, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of August 10, 2015 5.75% Convertible Senior Subordinated Exchange Notes due 2018...
Indenture Agreements
MANNKIND CORP
Biotechnology
DE
2015
SECOND AMENDMENT TO FACILITY AGREEMENT
Facility Agreements
MANNKIND CORP
Biotechnology
NY
2014
TRANCHE B SENIOR SECURED NOTE
Note Agreements
MANNKIND CORP
Biotechnology
NY
2014
FIRST AMENDMENT TO FACILITY AGREEMENT AND REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
MANNKIND CORP
Biotechnology
NY
2014
MANNKIND CORPORATION Common Stock (par value $0.01 pershare) At-The-Market Issuance Sales Agreement
Stock Agreements
MANNKIND CORP
Biotechnology
NY
2014
MANNKIND CORPORATION Common Stock (par value $0.01 pershare) At-The-Market Issuance Sales Agreement
Stock Agreements
MANNKIND CORP
Biotechnology
NY
2014
AMENDED AND RESTATED SENIOR SECURED CONVERTIBLE NOTE
Note Agreements
MANNKIND CORP
Biotechnology
NY
2014
MANNKIND CORPORATION Common Stock (par value $0.01 per share) At-The-Market Issuance Sales Agreement
Stock Agreements
MANNKIND CORP
Biotechnology
NY
2013
MANNKIND CORPORATION Common Stock (par value $0.01 per share) At-The-Market Issuance Sales Agreement
Stock Agreements
MANNKIND CORP
Biotechnology
NY
2013